No Data
No Data
We're Not Very Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Rate
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares
Olema Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Olema Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Express News | HC Wainwright & Co. Maintains Buy on Olema Pharmaceuticals, Raises Price Target to $28
Olema Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 147.13% HC Wainwright & Co. $25 → $28 Maintains Buy 04/02/2024 111.83% Goldman Sachs → $24 Init
Buy Rating on Olema Pharmaceuticals Amid Promising Clinical Trials and Strong Financial Position
Analysts Offer Insights on Healthcare Companies: Olema Pharmaceuticals (OLMA), 2seventy Bio (TSVT) and Marinus (MRNS)